CXCL10 is upregulated during active IBD, attracting activated T-lymphocytes, particularly Th1 cells (75, 82, 83), while CCL25 directs both T-lymphocytes and dendritic cells (81). This evidence concerns the gene CCL25 and inflammatory bowel disease.